Placebo News and Research

RSS

New drug appears to decrease inflammation in the brain linked to Alzheimer's disease

An experimental drug shows promise in treating Alzheimer's disease by preventing inflammation and removing abnormal protein clumps in the brain that are associated with the disease, suggests a study in mice presented at the ANESTHESIOLOGY 2016 annual meeting.

25 Oct 2016

Swiss specialists report success of new cell-based repair technology for articular cartilage defects

Writing in The Lancet, Swiss doctors report that cartilage cells harvested from patients’ own noses have been used to successfully produce cartilage transplants for the treatment of the knees of 10 adults (aged 18-55 years) whose cartilage was damaged by injury.

24 Oct 2016

Novel Alzheimer's treatment uses microscopic droplets of fat to carry drugs into the brain

Researchers have developed a novel treatment that could block the development of Alzheimer's disease using microscopic droplets of fat to carry drugs into the brain.

20 Oct 2016

BetterYou’s oral spray effective in correcting vitamin D insufficiency in athletes, study shows

The findings of a study by Ulster University in conjunction with health pioneers BetterYou, have confirmed existing literature showing how athletes, despite spending an above average amount of time outdoors, are still at risk of vitamin D deficiency.

From BetterYou Ltd 19 Oct 2016

Novel toothpaste produces significant reductions in dental plaque and inflammation

For decades, research has suggested a link between oral health and inflammatory diseases affecting the entire body -- in particular, heart attacks and strokes.

19 Oct 2016

Natural compound found in red wine can lower testosterone levels in women with PCOS

Resveratrol—a natural compound found in red wine and grapes—can help address a hormone imbalance in women with polycystic ovary syndrome (PCOS), a leading cause of infertility in women, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

19 Oct 2016

Folinic acid treatment could help improve language and communication skills of children with ASD

Prescription doses of folinic acid, which is a reduced form of a B vitamin known as folate, could help improve the language and communication skills of children with autism spectrum disorder (ASD).

18 Oct 2016

Study finds adequate levels of vitamin D among adolescents in the UK

A study, published in the American Journal of Clinical Nutrition, has shown high levels of vitamin D inadequacy in UK adolescents, and - for the first time - identified the intake needed by adolescents in order to maintain adequate serum vitamin D levels during the winter time.

18 Oct 2016

Anti-inflammatory drugs may improve severity of depressive symptoms, study finds

Anti-inflammatory drugs similar to those used to treat conditions such as rheumatoid arthritis and psoriasis could in future be used to treat some cases of depression, concludes a review led by the University of Cambridge, which further implicates our immune system in mental health disorders.

18 Oct 2016

Scientists at NIH and Emory University induce sustained remission in SIV-infected monkeys

Scientists at the National Institutes of Health and Emory University have experimentally induced sustained remission of SIV, the simian form of HIV, in infected monkeys.

14 Oct 2016

Mild sedative could reduce risk of post-operative delirium

A mild sedative could greatly reduce the risk of people experiencing delirium after an operation, according to new research.

14 Oct 2016

Knowingly taking placebo pills can help alleviate chronic back pain, study finds

Conventional medical wisdom has long held that placebo effects depend on patients' belief they are getting pharmacologically active medication.

14 Oct 2016

UA study questions safety and efficacy of selenium in reducing risk of colorectal cancer

A 12-year study led by a team of University of Arizona Cancer Center researchers is bringing into question the safety and efficacy of selenium, a popular nutritional supplement touted to combat and reduce the risk of colorectal cancer.

14 Oct 2016

Clinical study to determine safety, efficacy of allogeneic CDCs for patients with myocardial infarction

A multi-center team of researchers are planning a clinical trial using cardiosphere-derived cells (CDCs) (a heterogeneous cluster of proliferating cardiac cells that include mesenchymal stem cells) to regenerate the tissue and improve function of the heart in patients who have suffered heart attacks (myocardial infarction, MI).

13 Oct 2016

Study to investigate clinical impact of new treatment for HFrEF patients

The academic partners in the VerICiguaT GlObal Study in Subjects with Heart Failure with Reduced EjectIon FrAction are pleased to announce that patient enrollment has begun.

12 Oct 2016

DHA supplementation enhances cognitive function in older adults with MCI

Results from a recent study published in the Journal of Alzheimer's Disease support the cognitive benefits of DHA, which have been consistently demonstrated with doses of 900 mg/day or greater.

12 Oct 2016

Botanical supplements may reduce effectiveness of common anti-tuberculosis drug, study finds

Botanical supplements are used by people around the world to treat a wide range of physical and mental ailments. Some of these botanical supplements have high levels of antioxidants, which may have some positive health effects for certain conditions.

12 Oct 2016

Study to examine efficacy of orally administered medication in treating stuttering

Stuttering, an interruption in the flow of speech, affects about three million Americans. It begins most often in childhood, affecting four men for every woman. A precise cause of this complex communicative disorder is not known.

8 Oct 2016

Combination treatment with CDK4/6 inhibitor improves progression-free survival in HR+ breast cancer patients

The addition of the CDK4/6 inhibitor ribociclib to letrozole therapy significantly improves progression-free survival in postmenopausal women with hormone receptor-positive advanced breast cancer, researchers reported today at the ESMO 2016 Congress in Copenhagen.

8 Oct 2016

PARP inhibitor prolongs progression-free survival in patients with recurrent ovarian cancer

The PARP inhibitor niraparib significantly improves the outcome of platinum-sensitive recurrent ovarian cancer, according to full data from the ENGOT-OV16/NOVA trial presented for the first time at the ESMO 2016 Congress in Copenhagen and published in the New England Journal of Medicine.

8 Oct 2016

Placebo News and Research

New drug appears to decrease inflammation in the brain linked to Alzheimer's disease

Swiss specialists report success of new cell-based repair technology for articular cartilage defects

Novel Alzheimer's treatment uses microscopic droplets of fat to carry drugs into the brain

BetterYou’s oral spray effective in correcting vitamin D insufficiency in athletes, study shows

Novel toothpaste produces significant reductions in dental plaque and inflammation

Natural compound found in red wine can lower testosterone levels in women with PCOS

Folinic acid treatment could help improve language and communication skills of children with ASD

Study finds adequate levels of vitamin D among adolescents in the UK

Anti-inflammatory drugs may improve severity of depressive symptoms, study finds

Scientists at NIH and Emory University induce sustained remission in SIV-infected monkeys

Mild sedative could reduce risk of post-operative delirium

Knowingly taking placebo pills can help alleviate chronic back pain, study finds

UA study questions safety and efficacy of selenium in reducing risk of colorectal cancer

Clinical study to determine safety, efficacy of allogeneic CDCs for patients with myocardial infarction

Study to investigate clinical impact of new treatment for HFrEF patients

DHA supplementation enhances cognitive function in older adults with MCI

Botanical supplements may reduce effectiveness of common anti-tuberculosis drug, study finds

Study to examine efficacy of orally administered medication in treating stuttering

Combination treatment with CDK4/6 inhibitor improves progression-free survival in HR+ breast cancer patients

PARP inhibitor prolongs progression-free survival in patients with recurrent ovarian cancer

Industry Focus eBook - Life Science Microscopy (2nd Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News